Emcure Pharma Q2 Results: Net profit rises 38% to Rs 202 crore, revenue jumps 20%
Emcure Pharmaceuticals on Thursday reported a 38.2% year-on-year (YoY) increase in net profit to Rs.202 crore in Q2FY25 led by strong performance of domestic and international business
The Pune-based drug maker posted Rs 145.8 crore in the same period last year.
Revenue grew by 20.4% YoY to Rs 2,002 crore, up from Rs 1,663 crore in Q2 last fiscal.
The company’s EBITDA rose 26% YoY to Rs 417 crore crore, while the EBITDA margin stood at 20.8%
The domestic business grew 15.4% YoY to Rs 933 crore in Q2FY25 led by a steady performance of base business and aided by Sanofi distribution agreement.
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Commodity Markets Made Easy: Commodity Trading Course
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Point & Figure Chart Mastery: A Comprehensive Trading Guide
By — Mukta Dhamankar, Full Time Trader, 15 Years Experience, Instructor
Stock Trading
Options Trading Made Easy: Options Trading Course
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Stock Trading
Ichimoku Trading Unlocked: Expert Analysis and Strategy
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Macroeconomics Made Easy: Online Certification
